Efficacy of Ledipasvir/Sofosbuvir plus Ribavirin (SOF/LDV+RBV) in patient with chronic hepatitis C genotype 3 and compensated liver disease
Latest Information Update: 09 Oct 2018
At a glance
- Drugs Ledipasvir/sofosbuvir (Primary) ; Ribavirin (Primary)
- Indications Hepatitis C
- Focus Therapeutic Use
Most Recent Events
- 09 Oct 2018 New trial record